Neonatal salt wasting syndrome: Aldosterone synthase deficiency caused by a new splicing variant in CYP11B2

Arch Pediatr. 2024 Feb;31(2):157-160. doi: 10.1016/j.arcped.2023.10.007. Epub 2024 Jan 22.

Abstract

Aldosterone synthase deficiency (ASD) is a rare autosomal recessive disorder involving isolated aldosterone deficiency without any compromise of other adrenal hormones. This condition manifests mainly in the neonatal period and in infants as a salt wasting syndrome with vomiting and failure to thrive. Due to its potentially life-threatening effects, ASD requires a careful and early diagnosis based on appropriate hormonal investigations in order to initiate adequate management: rehydration as well as salt and fludrocortisone supplementation. Genetic analysis of the CYP11B2 gene will confirm ASD in most cases. We report the case of a newborn with a typical clinical presentation associated with some uncommon phenotypic features (hyperhidrosis, liver injury). Furthermore, our patient carries a new CYP11B2 splicing variant to be added to the approximately 60 pathogenic or likely pathogenic variants already reported.

Keywords: Aldosterone synthase deficiency; Newborn; Salt wasting syndrome.

Publication types

  • Case Reports

MeSH terms

  • Cytochrome P-450 CYP11B2* / genetics
  • Humans
  • Infant
  • Infant, Newborn

Substances

  • Cytochrome P-450 CYP11B2